APA aipamena

Wu, X., Tang, P., Li, S., Wang, S., Liang, Y., Zhong, L., . . . Zhang, Y. (2018). A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer. Nat Commun.

Chicago Style aipamena

Wu, Xiujuan, Peng Tang, Shifei Li, Shushu Wang, Yueyang Liang, Ling Zhong, Lin Ren, Ting Zhang, and Yi Zhang. "A Randomized and Open-label Phase II Trial Reports the Efficacy of Neoadjuvant Lobaplatin in Breast Cancer." Nat Commun 2018.

MLA aipamena

Wu, Xiujuan, et al. "A Randomized and Open-label Phase II Trial Reports the Efficacy of Neoadjuvant Lobaplatin in Breast Cancer." Nat Commun 2018.